THE FREQUENCY OF HLA-B*57:01 AND THE RISK OF ABACAVIR HYPERSENSITIVITY REACTIONS IN THE COSTA RICA CENTRAL VALLEY POPULATION

被引:0
|
作者
Arrieta-Bolanos, Esteban [1 ,2 ]
Madrigal, J. Alejandro [3 ,4 ]
Shaw, Bronwen E. [3 ,4 ,5 ]
Marsh, Steven G. E. [3 ,4 ]
Salazar-Sanchez, Lizbeth [2 ]
机构
[1] Univ Costa Rica, Anthony Nolan Res Inst, UCL Canc Inst, San Jose, Costa Rica
[2] Univ Costa Rica, Ctr Invest Hematol & Trastornos Afines CIHATA, San Jose, Costa Rica
[3] UCL Canc Inst, London, England
[4] Anthony Nolan Res Inst, London, England
[5] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, London SW3 6JB, England
来源
TISSUE ANTIGENS | 2012年 / 79卷 / 06期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:525 / 525
页数:1
相关论文
共 50 条
  • [1] The frequency of HLA-B*57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica
    Arrieta-Bolanos, Esteban
    Madrigal, J. Alejandro
    Marsh, Steven G. E.
    Shaw, Bronwen E.
    Salazar-Sanchez, Lizbeth
    HUMAN IMMUNOLOGY, 2014, 75 (11) : 1092 - 1096
  • [2] THE FREQUENCY OF HLA-B*57:01 AND THE RISK OF ABACAVIR HYPERSENSITIVITY REACTIONS IN THE INDIAN POPULATION: A PILOT STUDY
    Chowdhry, Mohit
    Makroo, R. N.
    Bhadauria, Preeti
    Mishra, Manoj
    Nag, Nalin
    TISSUE ANTIGENS, 2013, 81 (05): : 376 - 376
  • [3] Abacavir hypersensitivity beyond HLA-B*57:01; prediction for new alleles
    Lammerts, Rosa
    Vivian, Julian
    Illing, Patricia
    Kouprie, Niels
    Bungener, Laura
    Hepkema, Bouke
    HLA, 2022, 99 (05) : 434 - 434
  • [4] RELEVANCE OF HLA-B*57:01 SCREENING FOR ABACAVIR HYPERSENSITIVITY IN NORTH INDIANS
    Kanga, Uma
    Sharma, Gaurav
    Sharma, Akanksha
    Alwadhi, Ajeet
    Abid, Mohd
    Gautam, Sashi K.
    HUMAN IMMUNOLOGY, 2019, 80 : 106 - 106
  • [5] HLA-B*57:01 genotyping in the prevention of hypersensitivity to abacavir: 5 years of experience
    Ruiz-Iruela, Cristina
    Padulles-Zamora, Nuria
    Podzamczer-Palter, Daniel
    Alonso-Pastor, Arnald
    Candas-Estebanez, Beatriz
    Alia-Ramos, Pedro
    Padro-Miquel, Ariadna
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (08): : 390 - 396
  • [6] RELEVANCE OF HLA-B*57:01 SCREENING FOR ABACAVIR HYPERSENSITIVITY AMONG NORTH INDIANS
    Kanga, Uma
    Sharma, Akanksha
    Alwadhi, Ajit
    Kapoor, Shashi
    Abid, Mohd.
    HLA, 2020, 95 (04) : 356 - 357
  • [7] HLA-B*57:01-dependent intracellular stress in keratinocytes triggers dermal hypersensitivity reactions to abacavir
    Kazaoka, Akira
    Fujimori, Sota
    Yamada, Yushiro
    Shirayanagi, Tomohiro
    Gao, Yuying
    Kuwahara, Saki
    Sakamoto, Naoki
    Susukida, Takeshi
    Aoki, Shigeki
    Ito, Kousei
    PNAS NEXUS, 2024, 3 (04):
  • [8] Screening for HLA-B*5701 reduces the frequency of abacavir hypersensitivity reactions
    Reeves, I.
    Churchill, D.
    Fisher, M.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L11 - L11
  • [9] CD4+ T cells prevent abacavir hypersensitivity reactions in HLA-B*57:01 transgenic mice
    Cardone, Marco
    Garcia, Karla
    Yano, Masahide
    Mattson, Elliot
    Juengst, Leslie
    Roderiquez, Gregory
    Tilahun, Mulualem E.
    Boyd, Lisa F.
    Natarajan, Kannan
    Puig, Montserrat
    Margulies, David H.
    Norcross, Michael A.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [10] HLA-B*57 typing for detection of susceptibility to abacavir hypersensitivity
    Poole, K.
    Morris, G.
    Monteiro, E.
    Clarke, B.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2007, 34 (04) : 312 - 312